Dr Karen Best

School of Medicine

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Available For Media Comment.


Dr Karen Best is a midwife, clinical trialist and maternal and child health researcher. She is a Principal Research Fellow and leads the Pregnancy and Newborn Health Research Program at the South Australian Health and Medical Research Institute. Her research spans perinatal nutrition, preterm birth prevention, maternal mental health, child development, evidence synthesis and the long-term follow-up of mothers and children. She has secured more than $14 million in competitive research funding to support national trials and translational research programs.
 
The Pregnancy and Newborn Health Research Program aims to improve outcomes for women, babies and children by identifying modifiable factors during pregnancy and early life, testing how they influence maternal and infant health, and translating effective interventions into routine care. A defining achievement has been the successful translation of omega-3 evidence into a world-first routine antenatal testing pathway in South Australia, combining early-pregnancy testing with targeted supplementation advice to help prevent early preterm birth.
 
Karen leads major national studies, including the PoppiE trial of iodine supplementation and child cognitive outcomes, omega-3 precision nutrition research, evidence synthesis, maternal mental health studies and long-term follow-up of children through clinical, survey and linked-data approaches. Her program brings together women and families, clinicians, researchers, health services and policymakers to ensure research has practical and measurable impact.
 
Karen welcomes enquiries from prospective Masters and PhD students, early-career researchers and collaborators interested in maternal and child health, clinical trials, perinatal nutrition, implementation research, evidence synthesis, linked data and translating evidence into practice.
 

My Research

My research investigates how modifiable factors during pregnancy and early life can improve the health of women, babies and children, and how effective interventions can be embedded into routine care.

As a midwife and clinical trialist, I focus on research questions that matter directly to women, families and maternity services. My program brings together large clinical trials, evidence synthesis, implementation science and long-term follow-up to move research from discovery through to clinical guidelines, health services and policy.

Perinatal nutrition and national clinical trials

I lead and coordinate multicentre studies examining nutritional interventions during pregnancy and early life, including omega-3 fatty acids, iodine and folate.

I am the Coordinating Principal Investigator of PoppiE, a national randomised trial investigating the amount of iodine supplementation needed during pregnancy to support optimal child cognitive development. PoppiE uses a decentralised model incorporating online screening, remote consent and distributed follow-up across six Australian centres. More than 8,300 women were screened and 794 enrolled.

The PoppiE Study

I was also the operational lead of the Omega-3 fats to Reduce the Incidence of Prematurity, or ORIP, trial. This national randomised trial enrolled 5,544 women and generated important evidence that the effects of omega-3 supplementation differ according to a woman’s omega-3 status early in pregnancy.

Preventing preterm birth through precision nutrition

A defining focus of my research is translating evidence into maternity care to prevent early preterm birth.

Building on findings from the ORIP trial, I led the Omega-3 Test-and-Treat Program in South Australia. This world-first precision nutrition pathway combines omega-3 testing in early pregnancy with supplementation advice tailored to each woman’s result.

The Omega-3 Test-and-Treat Program

Through partnerships with women and families, clinicians, SA Pathology, maternity services and policymakers, this research has moved from a clinical trial evidence into routine antenatal care across South Australia. My omega-3 research has also contributed to Australian and international pregnancy care guidance.

Media Release - Handover of omega-3 testing to SA Pathology and routine care

My current research is examining how this pathway can be strengthened and extended, including national implementation.

Long-term maternal and child health

Interventions during pregnancy may affect health and development well beyond birth. I lead long-term follow-up studies examining childhood cognition, behaviour, education, allergy and respiratory health.

These studies use clinical assessments, parent-reported outcomes and linked health and education data. By connecting trial information with routinely collected data, we can answer important long-term questions while reducing the burden of research participation for families.

My doctoral research examined whether prenatal omega-3 supplementation influenced allergic disease in children at six years of age. This work established my continuing interest in understanding not only whether pregnancy interventions affect birth outcomes, but whether benefits or risks persist across childhood.

Evidence synthesis and clinical guidance

I lead and contribute to systematic reviews, meta-analyses, position statements and clinical guidance in pregnancy nutrition and maternal and child health.

Evidence synthesis is central to my research because it identifies which interventions are ready for implementation, where clinical recommendations need refinement and where new trials are required. I am particularly interested in understanding why intervention effects differ according to factors such as baseline nutritional status, dose, timing and participant characteristics.

Clinical trial innovation

I develop practical approaches to make pregnancy and child health trials more accessible, inclusive and efficient.

My work includes decentralised trial methods, digital recruitment, remote consent, online follow-up, linked data and strategies to improve participant retention. These approaches can reduce travel and participation burden, broaden access to research and support the delivery of complex national studies.

Collaboration and research opportunities

My research is highly collaborative and brings together women and families, midwives, clinicians, researchers, health services, pathology providers, policymakers and professional organisations across Australia and internationally.

I welcome enquiries from prospective Masters and PhD students, particularly midwives, clinicians and researchers interested in:

  • maternal and child health
  • pregnancy and perinatal nutrition
  • preterm birth prevention
  • maternal mental health
  • clinical trials and evidence synthesis
  • implementation and health services research
  • linked health and education data
  • long-term child development
  • translating research into policy and routine care
Remote video URL

 

 

Date Position Institution name
2022 - ongoing Director SAHMRI
2016 - 2022 Afiliate Senior Lecturer University of Adelaide
2016 - ongoing Post-doctoral Research Fellow South Australian Health & Medical Research Institute
2015 - ongoing Research Fellow South Australian Health and Medical Research Institute, Adelaide
2009 - 2012 Clinical Trial Project Manager Baker IDI Heart and Diabetes Institute, Melbourne
2005 - 2009 Clinical Trial Manager Women's & Children's Health Research Institute, North Adelaide
1990 - 1991 Registerd Midwife The Queen Victoria Hospital
1984 - 1987 Registered Nurse The Queen Elizabeth Hospital

Date Type Title Institution Name Country Amount
2026 Recognition NHMRC Research Translation - Case Study NHMRC Australia -
2025 Award Women’s Excellence in Research Award Healthy Development Adelaide Australia $1000
2025 Award Translation and Impact Award SAHMRI Australia -
2025 Recognition NHMRC ‘10 of the Best Research Projects’, Fifteenth Edition NHMRC Australia -
2024 Recognition NHMRC Research Impact Case Study NHMRC Australia -
2024 Scholarship Emerging Leaders Fellowship Mentoring Program Women’s Health Research Translation Network Australia -
2020 Achievement Runner-up ACTA Trial of the Year Australian Clinical Trials Alliance Australia -
2019 Fellowship MS McLeod Post-Doctoral Fellowship Women's and Children's Hospital Foundation Australia -
2018 Award ISSFAL Early Career Award International Society for the Study of Fatty Acids and Lipids (ISSFAL) United States -
2016 Achievement Winner South Australian 'Fresh Science' Competition Science In Public, Victoria. Australia -
2016 Award Travel Grant Healthy Development Adelaide Australia $1000
2016 Scholarship Research and Ethics Training Scholarship Praxis Australia - $1000.00
2015 Recognition Deans Commendation Doctoral thesis Excellence University of Adelaide Australia -
2013 Scholarship MS McLeod Peadiatric/Child Health Nursing Scholarship MS McLeod Foundation Australia -

Date Institution name Country Title
2012 - 2015 University of Adelaide Australia PhD Medicine
2005 - 2007 University of Canberra Australia Advance Certificate Clinical Trial Management
1991 - 1992 The Queen Victoria Hospital Australia Graduate Midwife Program
1990 - 1991 The Queen Victoria Hospital Australia Registered Midwifery Certificate
Queen Elizabeth Hospital, Adelaide Australia Registered Nursing Certificate

Date Title Institution Country
2012 - 2015 PhD Medicine University of Adelaide, Adelaide Australia
2005 - 2007 Graduate Certificate Clinical Trial Management University of Canberra Australia

Date Title Institution name Country
Registered Midwifery Certificate Queen Victoria Hospital Australia
Registered Nursing Certificate The Queen Elizabeth Hospital -

Year Citation
2026 Haji Ali Afzali, H., Linedale, E., Martin, C., Ahmed, M., Quinlivan, J., McPhee, A. J., . . . Best, K. P. (2026). Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia Compared with Current Practice. Clinicoeconomics and Outcomes Research, 18, 13 pages.
DOI
2026 Best, K. P., Gibson, R., Mugford, M., Bednarz, J., Linedale, E. C., Dimasi, C. G., . . . Makrides, M. (2026). Serum fatty acid distributions and prevalence of low omega-3 status in early pregnancy: A cross-sectional analysis of 26,389 samples from an omega-3 test-and-treat program. Prostaglandins Leukotrienes and Essential Fatty Acids, 210, 7 pages.
DOI
2025 Gould, J. F., Hines, S., Best, K. P., Grzeskowiak, L. E., Jansen, O., & Green, T. J. (2025). Choline During Pregnancy and Child Neurodevelopment: A Systematic Review of Randomized Controlled Trials and Observational Studies. Nutrients, 17(5), 886-1-886-18.
DOI Scopus3 WoS3 Europe PMC2
2025 Sullivan, T. R., Green, T. J., Gould, J. F., Makrides, M. M., & Best, K. P. (2025). Statistical analysis plan for the Prenatal Iodine Supplementation and Early Childhood Neurodevelopment (PoppiE) randomised controlled trial. Trials, 26(1), 162-1-162-10.
DOI Scopus2 WoS2 Europe PMC1
2025 Best, K. P., Yelland, L. N., Ge, L., Shi, Z., Leemaqz, S., Gibson, R., . . . Middleton, P. (2025). Maternal phthalate exposure, gestational length, and preterm birth risk: a prospective cohort study nested within a randomised trial. BMC Pregnancy and Childbirth, 25(1), 830-1-830-11.
DOI
2025 Best, K. P., Northcott, C., Simmonds, L. A., Middleton, P., Yelland, L. N., Moffa, V., . . . Makrides, M. (2025). The early implementation phase of the Omega-3 Test-and-Treat Program for reducing the risk of preterm birth, South Australia, 2021-22: an implementation evaluation study. Medical Journal of Australia, 223(11), 626-633.
DOI Scopus2 WoS2
2025 Mugford, M., Arman, B. M., Kumar, K., Kaluve, R. S., Tran, D. X. A., Best, K., . . . Gibson, R. A. (2025). Associations between fatty acids providing support for n-3 and n-6 pathways are strongest in pregnant Indian vegetarians compared with pregnant Australian omnivores. Prostaglandins Leukotrienes and Essential Fatty Acids, 207, 102714-1-102714-10.
DOI Scopus1 WoS1
2024 Sullivan, T. R., Best, K. P., Gould, J., Zhou, S. J., Makrides, M., & Green, T. J. (2024). Too much too little: clarifying the relationship between maternal iodine intake and neurodevelopmental outcomes. The Journal of Nutrition, 154(1), 185-190.
DOI Scopus15 WoS12 Europe PMC11
2024 Gould, J. F., Roberts, R. M., Anderson, P. J., Makrides, M., Sullivan, T. R., Gibson, R. A., . . . Collins, C. T. (2024). High-Dose Docosahexaenoic Acid in Newborns Born at Less Than 29 Weeks' Gestation and Behavior at Age 5 Years: Follow-Up of a Randomized Clinical Trial. JAMA Pediatrics, 178(1), 45-54.
DOI Scopus8 WoS8 Europe PMC7
2024 Elms, L., Hand, B., Skubisz, M., Best, K. P., Grzeskowiak, L. E., Rogers, G. B., . . . Taylor, S. L. (2024). The effect of iron supplements on the gut microbiome of women of reproductive age: A randomized controlled trial. J Nutr, 154(5), 1582-1587.
DOI Scopus3 WoS2 Europe PMC3
2024 Sulistyoningrum, D. C., Sullivan, T. R., Skubisz, M., Palmer, D. J., Wood, S., Ueland, P. M., . . . Best, K. P. (2024). Maternal serum unmetabolized folic acid concentration following multivitamin and mineral supplementation with or without folic acid after 12 weeks gestation: A randomized controlled trial. Maternal and Child Nutrition, 20(4), e13668-1-e13668-10.
DOI Scopus6 WoS6 Europe PMC5
2024 Teede, H. J., Best, K., Bloomfield, F. H., Cass, A., Cohen, P., Crengle, S., . . . Webb, S. (2024). Implementability and impact in clinical research and the role of clinical trial networks. Medical Journal of Australia, 221(8), 410-413.
DOI Scopus1 WoS1 Europe PMC1
2023 Best, K. P., Sullivan, T. R., Gunaratne, A. W., Gould, J. F., Gibson, R. A., Collins, C. T., . . . Green, T. J. (2023). Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial. Nutrients, 15(2), 335.
DOI Scopus6 WoS5 Europe PMC5
2023 Yelland, L. N., Sullivan, T. R., Gibson, R. A., Simmonds, L. A., Thakkar, S. K., Huang, F., . . . Makrides, M. (2023). Identifying women who may benefit from higher dose omega-3 supplementation during pregnancy to reduce their risk of prematurity: exploratory analyses from the ORIP trial.. BMJ Open, 13(4), e070220.
DOI Scopus5 WoS5 Europe PMC5
2023 Best, K. P., Gould, J. F., Makrides, M., Sullivan, T., Cheong, J., Zhou, S. J., . . . Green, T. (2023). Prenatal iodine supplementation and early childhood neurodevelopment: the PoppiE trial - study protocol for a multicentre randomised controlled trial. BMJ Open, 13(5), e071359-1-e071359-8.
DOI Scopus3 WoS3 Europe PMC3
2023 Best, K. P., Yelland, L. N., Collins, C. T., McPhee, A. J., Rogers, G. B., Choo, J., . . . Makrides, M. (2023). Growth of late preterm infants fed nutrient-enriched formula to 120 days corrected age-A randomized controlled trial.. Frontiers in pediatrics, 11, 1146089.
DOI Scopus2 WoS4 Europe PMC1
2023 Sullivan, T. R., Gould, J. F., Bednarz, J. M., McPhee, A. J., Gibson, R., Anderson, P. J., . . . Makrides, M. (2023). Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born Preterm. JAMA Network Open, 6(6), 1-11.
DOI Scopus13 WoS13 Europe PMC11
2023 Sullivan, T. R., Yelland, L. N., Gibson, R. A., Thakkar, S. K., Huang, F., Best, K. P., . . . Makrides, M. (2023). Predictors of compliance with higher dose omega-3 fatty acid supplementation during pregnancy and implications for the risk of prematurity: exploratory analysis of the ORIP randomised trial. BMJ Open, 13(9), e076507-1-e076507-8.
DOI Scopus1 WoS1 Europe PMC1
2022 Gibson, R. A., Makrides, M., Sullivan, T., Yelland, L. N., & Best, K. P. (2022). Response to Jackson and Harris, 2022;179:102417. Prostaglandins, Leukotrienes and Essential Fatty Acids, 182, 102454-1-102454-2.
DOI Scopus1 Europe PMC1
2022 Keir, A., Rumbold, A., Collins, C. T., McPhee, A. J., Varghese, J., Morris, S., . . . Best, K. P. (2022). Breastfeeding outcomes in late preterm infants: A multi-centre prospective cohort study. PLoS One, 17(8), 1-8.
DOI Scopus20 WoS20 Europe PMC15
2022 Probst, Y., Sulistyoningrum, D. C., Netting, M. J., Gould, J. F., Wood, S., Makrides, M., . . . Green, T. J. (2022). Estimated Choline Intakes and Dietary Sources of Choline in Pregnant Australian Women.. Nutrients, 14(18), 3819-1-3819-7.
DOI Scopus14 WoS12 Europe PMC12
2022 Best, K. P., Gibson, R. A., & Makrides, M. (2022). ISSFAL statement number 7 - Omega-3 fatty acids during pregnancy to reduce preterm birth.. Prostaglandins, Leukotrienes and Essential Fatty Acids, 186, 102495-1-102495-7.
DOI Scopus51 WoS47 Europe PMC31
2022 Gould, J. F., Makrides, M., Gibson, R. A., Sullivan, T. R., McPhee, A. J., Anderson, P. J., . . . Collins, C. T. (2022). Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 Years. New England Journal of Medicine, 387(17), 1579-1588.
DOI Scopus58 WoS56 Europe PMC47
2022 Swannell, C. (2022). Omega-3 fatty acid could boost IQ for preterm babies. MEDICAL JOURNAL OF AUSTRALIA, 217(10), 497.
2021 Best, K., & Green, T. J. (2021). Adequate maternal pre-conceptional folate status may reduce the risk of gestational diabetes mellitus.. Evidence-Based Nursing, 24(3), 79.
DOI Scopus2
2021 Best, K., Gomersall, J., & Makrides, M. (2021). Prenatal Nutritional Strategies to Reduce the Risk of Preterm Birth. Annals of Nutrition and Metabolism, 76(Suppl. 3), 31-39.
DOI Scopus13 WoS14 Europe PMC11
2021 Gould, J. F., Makrides, M., Sullivan, T. R., Anderson, P. J., Gibson, R. A., Best, K. P., . . . Collins, C. T. (2021). Protocol for assessing whether cognition of preterm infants <29 weeks' gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trial. BMJ Open, 11(2), e041597-1-e041597-6.
DOI Scopus7 WoS6 Europe PMC7
2021 Gould, J. F., Best, K., Netting, M. J., Gibson, R. A., & Makrides, M. (2021). New methodologies for conducting maternal, infant, and child nutrition research in the era of covid-19. Nutrients, 13(3), 1-11.
DOI Scopus8 WoS8 Europe PMC7
2021 Cumpston, M. S., Webb, S. A., Middleton, P., Sharplin, G., & Green, S. (2021). Understanding implementability in clinical trials: a pragmatic review and concept map. Trials, 22(1), 232-1-232-10.
DOI Scopus10 WoS9 Europe PMC7
2021 Best, K. P., Green, T. J., Sulistyoningrum, D. C., Sullivan, T. R., Aufreiter, S., Prescott, S. L., . . . Palmer, D. J. (2021). Maternal late-pregnancy serum unmetabolized folic acid concentrations are not associated with infant allergic disease: a prospective cohort study. The Journal of Nutrition, 151(6), 1553-1560.
DOI Scopus21 WoS17 Europe PMC15
2021 Gould, J. F., Roberts, R. M., Anderson, P. J., Makrides, M., Sullivan, T. R., Gibson, R. A., . . . Collins, C. T. (2021). Protocol for assessing if behavioural functioning of infants born <29 weeks' gestation is improved by omega-3 long-chain polyunsaturated fatty acids: follow-up of a randomised controlled trial. BMJ Open, 11(5), e044740-1-e044740-10.
DOI Scopus6 WoS4 Europe PMC5
2021 Best, K., Makrides, M., & Grivell, R. (2021). Optimising micronutrients during pregnancy. Medicine Today, 22(7), 29-36.
2021 Simmonds, L. A., Yelland, L. N., Best, K. P., Liu, G., Gibson, R. A., & Makrides, M. (2021). Translating n-3 polyunsaturated fatty acid status from whole blood to plasma and red blood cells during pregnancy: Translating n-3 status across blood fractions in pregnancy.. Prostaglandins, Leukotrienes and Essential Fatty Acids, 176, 102367.
DOI Scopus12 WoS10 Europe PMC6
2021 Best, K. P., Gomersall, J., & Makrides, M. (2021). Focus/Summary: Prenatal Nutritional Strategies to Reduce the Risk of Preterm Birth / Karen Patricia Best et al.. Annals of Nutrition and Metabolism, 76(Suppl. 3), 30.
DOI
2020 Ramsden, C. E., Makrides, M., Yuan, Z. -X., Horowitz, M. S., Zamora, D., Yelland, L. N., . . . Gibson, R. A. (2020). Plasma oxylipins and unesterified precursor fatty acids are altered by DHA supplementation in pregnancy: can they help predict risk of preterm birth?. Prostaglandins, Leukotrienes and Essential Fatty Acids, 153, 102041-1-102041-9.
DOI Scopus23 WoS22 Europe PMC20
2020 Douglas, C. A., Ivey, K. L., Papanicolas, L. E., Best, K. P., Muhlhausler, B. S., & Rogers, G. B. (2020). DNA extraction approaches substantially influence the assessment of the human breast milk microbiome. Scientific Reports, 10(1), 123-1-123-10.
DOI Scopus70 WoS69 Europe PMC76
2020 Simmonds, L. A., Sullivan, T. R., Skubisz, M., Middleton, P. F., Best, K. P., Yelland, L. N., . . . Makrides, M. (2020). Omega-3 fatty acid supplementation in pregnancy - baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology, 127(8), 975-981.
DOI Scopus87 WoS75 Europe PMC56
2020 Makrides, M., Best, K., Yelland, L., McPhee, A., Zhou, S., Quinlivan, J., . . . Gibson, R. (2020). A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery. Obstetrical and Gynecological Survey, 75(2), 79-80.
DOI
2020 Hunt, S. E., Netting, M. J., Sullivan, T. R., Best, K. P., Houghton, L. A., Makrides, M., . . . Green, T. J. (2020). Red Blood Cell Folate Likely Overestimated in Australian National Survey: Implications for Neural Tube Defect Risk.. Nutrients, 12(5), 1283-1-1238-6.
DOI Scopus9 WoS8 Europe PMC8
2020 Best, K. P., Gibson, R. A., Yelland, L. N., Leemaqz, S., Gomersall, J., Liu, G., & Makrides, M. (2020). Effect of omega-3 lcpufa supplementation on maternal fatty acid and oxylipin concentrations during pregnancy. Prostaglandins Leukot Essent Fatty Acids, 162, 102181-1-102181-9.
DOI Scopus10 WoS8 Europe PMC7
2020 Sulistyoningrum, D., Green, T., Palmer, D., Sullivan, T., Wood, S., Makrides, M., . . . Best, K. P. (2020). Study protocol for a randomised controlled trial evaluating the effect of folic acid supplementation beyond the first trimester on maternal plasma unmetabolised folic acid in late gestation.. BMJ Open, 10(11), e040416-1-e040416-7.
DOI Scopus7 WoS8 Europe PMC6
2019 Gunaratne, A. W., Makrides, M., Collins, C. T., Gibson, R. A., McPhee, A. J., Sullivan, T. R., . . . Best, K. P. (2019). Docosahexaenoic acid supplementation of preterm infants and parent-reported symptoms of allergic disease at 7 years corrected age: follow-up of a randomized controlled trial. American Journal of Clinical Nutrition, 109(6), 1600-1610.
DOI Scopus9 WoS7 Europe PMC7
2019 Makrides, M., Best, K., Yelland, L., McPhee, A., Zhou, S., Quinlivan, J., . . . Gibson, R. (2019). A randomized trial of prenatal n-3 fatty acid supplementation and preterm delivery. The New England journal of medicine, 381(11), 1035-1045.
DOI Scopus99 WoS85 Europe PMC64
2018 Best, K. P., Sullivan, T. R., Palmer, D. J., Gold, M., Martin, J., Kennedy, D., & Makrides, M. (2018). Prenatal omega-3 LCPUFA and symptoms of allergic disease and sensitization throughout early childhood - a longitudinal analysis of long-term follow-up of a randomized controlled trial. World Allergy Organization Journal, 11(1), 10-1-10-11.
DOI Scopus42 WoS35 Europe PMC28
2017 Gould, J., Best, K., & Makrides, M. (2017). Perinatal nutrition interventions and post-partum depressive symptoms. Journal of Affective Disorders, 224, 2-9.
DOI Scopus22 WoS18 Europe PMC13
2017 Best, K., & Makrides, M. (2017). Possible protective effect of prenatal omega-3 long-chain polyunsaturated fatty acids supplementation on persistent wheeze and asthma in early childhood. Evidence Based Medicine, 22(3), 104.
DOI Scopus6 Europe PMC5
2017 Zhou, S., Best, K., Gibson, R., McPhee, A., Yelland, L., Quinlivan, J., & Makrides, M. (2017). Study protocol for a randomised controlled trial evaluating the effect of prenatal omega-3 LCPUFA supplementation to reduce the incidence of preterm birth: the ORIP trial. BMJ Open, 7(9), e018360-1-e018360-9.
DOI Scopus19 WoS21 Europe PMC18
2016 Best, K., Gold, M., Kennedy, D., Martin, J., & Makrides, M. (2016). Omega-3 long-chain PUFA intake during pregnancy and allergic disease outcomes in the offspring: a systematic review and meta-analysis of observational studies and randomized controlled trials. American Journal of Clinical Nutrition, 103(1), 128-143.
DOI Scopus154 WoS123 Europe PMC101
2016 Best, K. P., Sullivan, T., Palmer, D., Gold, M., Kennedy, D. J., Martin, J., & Makrides, M. (2016). Prenatal fish oil supplementation and allergy: 6-year follow-up of a randomized controlled trial. Pediatrics, 137(6), 1-9.
DOI Scopus61 WoS56 Europe PMC45
2016 Makrides, M., & Best, K. (2016). Docosahexaenoic acid and preterm birth. Annals of Nutrition and Metabolism, 69(Suppl. 1), 30-34.
DOI Scopus20 WoS14 Europe PMC10
2010 Makrides, M., Gibson, R., McPhee, A., Yelland, L., Quinlivan, J., Ryan, P., . . . Griffith, E. (2010). Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial. Jama-journal of the American Medical Association, 304(15), 1675-1683.
DOI Scopus501 WoS441 Europe PMC381

Year Citation
2022 Netting, M. J., Best, K. P., & Green, T. J. (2022). The Role of Vitamin D in Anemia. In Nutrition and Health United Kingdom (Vol. Part F3941, pp. 195-204). Springer International Publishing.
DOI Scopus2
2018 Muhlhausler, B., Collins, C. T., Gould, J., Best, K. P., & Leghi, G. (2018). Polyunsaturated fatty acids: metabolism and nutritional requirements in pregnancy and infancy. In G. Burdge (Ed.), Polyunsaturated Fatty acid Metabolism (pp. 111-135). United Kingdom: Elsevier.
DOI Scopus7 WoS6

Year Citation
2023 Probst, Y., Sulistyoningrum, D. C., Netting, M. J., Gould, J., Makrides, M., Best, K. P., & Green, T. J. (2023). Choline intakes, dietary choline sources, and serum choline concentrations in early and late pregnancy. In PROCEEDINGS OF THE NUTRITION SOCIETY Vol. 82 (pp. 1 page). CAMBRIDGE UNIV PRESS.
DOI
2023 Sulistyoningrum, D. C., Sullivan, T. R., Skubisz, M., Palmer, D. J., Wood, S., Snel, M. F., . . . Best, K. P. (2023). Detection of serum unmetabolised folic acid at 36 weeks' gestation in pregnant women taking multi-vitamin and mineral supplements with or without 800 µg folic acid. In ANNALS OF NUTRITION AND METABOLISM Vol. 79 (pp. 495). KARGER.
2023 Green, T. J., Best, K. P., & Netting, M. J. (2023). The Emerging Role of Vitamin D Deficiency in Anemia. In ANNALS OF NUTRITION AND METABOLISM Vol. 79 (pp. 133). KARGER.
2022 Best, K., Yelland, L., Gibson, R., & Makrides, M. (2022). Omega-3 to Reduce the Incidence of Preterm Birth - from bench to bedside. In WOMEN AND BIRTH Vol. 35 (pp. S42). ELSEVIER.
DOI
2021 Best, K. (2021). Prenatal Omega-3 Supplementation for the Prevention of Preterm Birth-A Double Edged Sword?. In JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY Vol. 98 (pp. 226). WILEY.
2018 Best, K. (2018). Exposure to everyday chemicals: phthalate concentrations in pregnant women in Australia. In J Paediatr Child Health. 2018;54(S1):1-2.. Auckland.
2017 Best, K. (2017). Prenatal Omega-3 Supplementation and Allergy in Childhood.. In Journal of Developmental Origins of Health and Disease, 8(S1), S1-S449. doi:10.1017/S2040174417000848.. Rotterdam, The Netherlands.
2016 Best, K. (2016). Prenatal Omega-3 Supplementation and Allergy in Childhood.. In European journal of pediatrics. 2016; 175(11):1393-880. Geneva, Switzerland.
2015 Best, K. (2015). Six Year Follow Up of Children at High Hereditary Risk of Allergy, Born To Mothers Supplemented With Docosahexaenoic Acid (DHA) in the DOMInO Trial. In Journal of Peadiatrics and Child Health (2015) 51 S1 1-17. NSW, Australia.

Year Citation
2025 Best, K. P., Northcott, C., Simmonds, L. A., Middleton, P., Yelland, L. N., Moffa, V., . . . Makrides, M. (2025). Feasibility, Implementation and Early Adoption of an Omega-3 Test-and-Treat Program to Reduce Preterm Birth.
DOI
2022 Keir, A., Rumbold, A., Collins, C. T., McPhee, A. J., Varghese, J., Morris, S., . . . Best, K. P. (2022). Breastfeeding outcomes in late preterm infants: a multi-centre prospective cohort study.
DOI
2020 Best, K., Green, T., Sulistyoningrum, D., Sullivan, T., Aufreiter, S., Prescott, S., . . . Palmer, D. (2020). Maternal late-pregnancy serum unmetabolized folic acid concentrations are not associated with infant allergic disease - A prospective cohort study.
DOI
2020 Best, K. P., Gibson, R. A., Yelland, L. N., Leemaqz, S., Gomersall, J., Liu, G., & Makrides, M. (2020). Effect of omega-3 LCPUFA supplementation on maternal fatty acid and oxylipin concentrations during pregnancy.
DOI
Date Project Role Funding Body Amount
2023 Implementation of an omega-3 precision nutrition strategy to prevent preterm birth Principal Investigator MRFF $1,366,713
2024 A Platform for Adaptive Trials in Perinatal Units Associate Investigator MRFF $3,998,773
2023 Optimal dose of omega-3 fatty acids in pregnancy for women with moderate status Principal Investigator Nestle Institute of Health Sciences $300,000
2022 State-wide evaluation of maternal omega-3 precision nutrition to prevent prematurity Chief Investigator The Hospital Research Foundation  $500,000
2020 Is taking folic acid beyond early pregnancy too much of a good thing Principal Investigator SAHMRI Seed Funding $29,982
2020 Omega-3 status in pregnancy, supplementation and prematurity Chief Investigator Nestle Institute of Health Sciences $182,700
2020 Eggs to Improve Choline Intakes in Pregnancy Chief Investigator Australian Eggs $93,700
2020 Prenatal Iodine Supplementation
and Early Childhood Neurodevelopment - PoppiE
Principal Investigator MRFF $3,430,000
2020 Folic Acid in pregnancy Principal Investigator SAHMRI $30,000
2020 Detection of unmetabolised folic acid in pregnant women at 36 weeks gestation taking multinutrient supplements with or without folic acid Principal Investigator Women's and Children's Hospital Foundation $100,000
2019 The effect of maternal unmetabolized folic acid on allergic disease in the infant Principal Investigator Thrasher Research Fund (US) $30,000
2017 A randomized controlled trial to investigate nutritive effects of a cow’s milk-based infant formula on growth rates of late preterm infants Chief Investigator Mead Johnson Nutritionals
International Commercial
$2,200,000
2017 Omega-3 in breastmilk Chief Investigator BASF Newtrition Grant
International Commercial
$64,000
2017 Phthalates and preterm birth Chief Investigator/Clinical Project Manager Women's & Children's Hospital Foundation
Domestic, not for profit
$54,000
2013 Omega-3 fats to reduce the incidence of preterm birth. Chief Investigator/Clinical Project Manager NHMRC $4,021,840
2016 The Breast Milk Omega-3 Trial Chief Investigator BASF Newtrition $64,000
2015 Does fish oil supplementation reduce allergies in school age children? PhD Candidate/Student Investigator NHMRC $429,231
2005 DHA to optimise maternal and infant outcomes. Clinical Project Manager NHMRC $1,649,000
2003 Neurodevelopmental Outcomes of Preterm Infants Fed High-Dose Docosahexaenoic Acid Clinical Trial Coordinator NHMRC $615,000

Date Role Research Topic Program Degree Type Student Load Student Name
2026 Co-Supervisor Fit the Flange: Testing the feasibility and acceptability of a personalised flange fitting service to support breastmilk feeding for pre-term infants. Master of Research Master Part Time Ms Kate Louise Frawley
2024 Co-Supervisor The effects of omega-3 and aspirin supplementation on preterm birth rates Doctor of Philosophy Doctorate Full Time Mr Michael Ian Mugford

Date Role Research Topic Program Degree Type Student Load Student Name
2024 - 2025 Co-Supervisor From Evidence to Action: Implementing a Novel Omega-3 Test-and-Treat Program in Antenatal Care to Prevent Preterm Birth Doctor of Philosophy Doctorate Full Time Miss Celine Northcott
2019 - 2023 Co-Supervisor The effect of continued folic acid supplementation beyond the first trimester on unmetabolised folic acid in late gestation Doctor of Philosophy Doctorate Full Time Ms Dian Caturini Sulistyoningrum

Date Role Committee Institution Country
2025 - ongoing Member Translation of Research into Practice Special Interest Group Australian Clinical Trials Alliance Australia
2024 - ongoing Co-Chair Data Safety and Monitoring Committee Curtin University Australia
2023 - 2024 Member A-CTEC Conference Organising Committee Australian Clinical Trials Education Committee Australia
2022 - 2025 Member A-CTEC Conference Organising Committee Australian Clinical Trials Education Committee Australia
2022 - 2024 Member A-CTEC Steering Committee Australian Clinical Trial Education Committee Australia
2022 - 2024 Member Australian Teletrials Program SA Steering Committee Australian Teletrials Program Australia
2022 - 2024 Member Health Studies Australia National Data Asset (HeSANDA) Steering Committee Health Studies Australia National Data Asset Australia
2019 - 2022 Board Member SAHMRI Women and Kids Community Board SAHMRI Women and Kids Australia
2019 - 2024 Member Data Safety Monitoring Board Women's and Infant's Research Foundation Australia
2017 - 2020 Member DOHaD Council Developmental Origins of Health and Disease Society Australia
2017 - ongoing Member IMPACT Committee Interdisciplinary Maternal Perinatal Australasian Collaborative Trials Network Australia
2016 - ongoing Member Low-risk Human Research Ethics Committee University of Adelaide Australia

Date Title Type Institution Country
2024 - 2024 Independent Discipline Expert Advice Flinders University Australia
2024 - 2024 Independent Assessor, Major Review Thesis Review Flinders University Australia
2022 - 2022 Conference Abstract Reviewer Conference Review Australian College of Midwives Australia
2020 - ongoing Academy Member Conference Review Perinatal Society of Australia and New Zealand Australia

Connect With Me

External Profiles